Hong Kong/China M&A/Events

Hong Kong/China M&A/Events

ESR (1821 HK) Chips Away At Pre-Cons

Quiddity Research's avatar
Quiddity Research
Mar 11, 2025
∙ Paid
Share
  • When the Starwood/Warburg Pincus Consortium announced a firm offer on the 4th December, it was pre-conditional on a raft of regulatory approvals from no less than eight countries/jurisdictions.

  • We're half way there, with four approvals now squared away, leaving Australia, China, Hong Kong and New Zealand still to give the go ahead.

  • Irrevocables comprising 34.26% of the register (and 57.01% of disinterested shares) are now in the bag. This is a done deal. It's just a question of timing.

Keep reading with a 7-day free trial

Subscribe to Hong Kong/China M&A/Events to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Quiddity Investment Advisors
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture